Comprehensive genomic services supporting oncology studies

This presentation recognizes new sequencing technologies utilized in genomic testing warrants a flexbile approach to oversight and explores requirements of genomic services to support oncology studies. GLP-compliant and CLIA certified laboratory requirements and assays are presented for both preclinical and clinical drug development programs for cancer therapeutics. Comprehensive genomic service packages that support such oncology studies are also presented.

Click here to download the full presentation

In association with: